Auricular Point Acupressure for Pain
Effects of Auricular Point Acupressure for Chronic Musculoskeletal Pain in Older People With HIV: a Pilot Randomized Controlled Trial
1 other identifier
interventional
30
1 country
1
Brief Summary
The goal of this pilot clinical trial is to learn whether auricular point acupressure (APA) can help reduce chronic musculoskeletal pain in adults age 50 and older who are living with HIV. The study will also examine whether APA is feasible, acceptable, and safe for this population. The main questions it aims to answer are: Does APA reduce chronic musculoskeletal pain and improve sleep and quality of life? Is APA feasible, acceptable, and safe for older people living with HIV? Researchers will compare true APA, in which small seeds are taped to specific ear points related to pain, with sham APA, in which seeds are taped to ear points not related to pain. The intervention will last 4 weeks. Participants will: Receive true APA or sham APA for 4 weeks Visit the study site weekly for placement of the ear seeds Press the ear seeds for 3 minutes, 3 times each day Complete daily surveys about pain and pain medication use Use a sleep monitor to track sleep Complete study assessments at the beginning and end of the intervention Complete an exit interview about their experience with APA
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 23, 2026
CompletedFirst Posted
Study publicly available on registry
October 1, 2026
CompletedStudy Start
First participant enrolled
October 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2027
October 1, 2026
September 1, 2026
8 months
September 23, 2026
September 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Pain Intensity Assessed by the Numeric Pain Rating Scale (NRS)
Pain intensity will be assessed using the Numeric Pain Rating Scale (NRS), on which participants rate their pain from 0 (no pain) to 10 (worst possible pain). Higher scores indicate greater pain intensity. Change in pain intensity from baseline to the end of the 4-week intervention will be compared between the true APA and sham APA groups.
Baseline and 4 weeks
Secondary Outcomes (2)
Change in Health-Related Quality of Life Assessed by the EQ-5D
Baseline and 4 weeks
Change in Sleep Quality Assessed by the Withings Sleep Analyzer
Baseline through 4 weeks
Study Arms (2)
True APA group
EXPERIMENTALParticipants randomized to the true APA arm will receive a 4-week auricular point acupressure intervention targeting designated ear acupoints for chronic musculoskeletal pain.
Sham APA group
SHAM COMPARATORParticipants randomized to the sham APA arm will receive a 4-week sham auricular point acupressure intervention using ear points not associated with chronic musculoskeletal pain
Interventions
Participants will receive auricular point acupressure (APA) using Vaccaria seeds secured with adhesive tape to designated ear acupoints for chronic musculoskeletal pain. Both ears will be treated. Participants will be instructed to press the seeds for 3 minutes, 3 times daily. Treatment will continue for 4 weeks, with each weekly cycle consisting of 5 days of wearing the seeds followed by 2 days without the seeds. Seeds will be replaced weekly by trained study personnel.
Participants will receive sham auricular point acupressure using the same materials, treatment schedule, and procedures as the APA group. However, Vaccaria seeds will be placed on non-specific ear points unrelated to chronic musculoskeletal pain. Participants will press the seeds for 3 minutes, 3 times daily for 4 weeks, following the same weekly treatment cycle as the APA group.
Eligibility Criteria
You may qualify if:
- Age 50 years or older
- Living with HIV
- Chronic musculoskeletal pain affecting the muscles, joints, or bones for at least 3 months
- Average chronic musculoskeletal pain intensity of ≥4 on a 0-10 Numeric Pain Rating Scale during the past week
You may not qualify if:
- Recent trauma as the primary cause of pain
- Concurrent use of other adjunctive pain therapies, including physical therapy, chiropractic treatment, or acupuncture
- Allergy to latex due to the use of latex-containing tape on the ear points Presence of acute pain
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dan Songlead
Study Sites (1)
Texas A&M University-Corpus Christi
Corpus Christi, Texas, 78414, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Participants will be masked to treatment assignment. Participants in both groups will receive taped ear seeds using the same treatment schedule and procedures; however, the true APA group will receive seeds placed on designated acupoints for chronic musculoskeletal pain, whereas the sham APA group will receive seeds placed on non-specific ear points unrelated to chronic musculoskeletal pain.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
September 23, 2026
First Posted
October 1, 2026
Study Start
October 1, 2026
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
September 1, 2027
Last Updated
October 1, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share
No. Individual participant data are not planned to be shared with researchers outside the study team. Study findings will be disseminated in aggregate form.